Brazil faces significant delays in rare disease and autism diagnoses

Studies in Brazil highlight significant delays in medical diagnoses for both rare diseases and autism. According to the Rede Brasileira de Doenças Raras, patients with rare diseases face an average of five years between the onset of symptoms and a definitive diagnosis. Similarly, research published in the European Journal of Human Genetics found a four-year average for diagnosis confirmation across 1,675 rare diseases.

In the context of oncology, timing is critical; for example, the five-year survival rate for localized colon cancer is 91%, compared to just 13% once the disease has spread to distant organs. Experts suggest that transforming existing patient data into actionable clinical intelligence could help bridge this diagnostic gap.

Regarding neurodevelopment, a review of studies led by the Instituto de Pesquisa Pelé Pequeno Príncipe identified delays of up to 49 months between caregivers noticing signs of autism and receiving a formal diagnosis. The research, involving over 24,000 participants, suggests these delays result from a sequence of missed opportunities, including lack of structured investigation following initial concerns and long waiting lists for specialists.